Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Link

Showing results (481-490 of 673) with videos related to

Pageof 68
Sort By:
International Immunology|September 29, 2000
Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravisH B Wang, H Li, F D Shi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2001
Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravisH B Wang, F D Shi, H Li, et al.
Langenbeck'S Archives of Surgery|June 26, 1998
Resection and radiochemotherapy of pancreatic cancer--the future?K H Link, A Formentini, G Leder, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2008
Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1A Sanna, Y M Huang, G Arru, et al.
Journal of Neuroimmunology|January 1, 1996
Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosisV Navikas, D Matusevicius, M Söderström, et al.
The New England Journal of Medicine|May 12, 1988
Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coliC O Tacket, G Losonsky, H Link, et al.
Clinical Immunology (Orlando, Fla.)|August 31, 2000
Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis ratsL Y Xu, J S Yang, Y M Huang, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 13, 1999
Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment conceptsK H Link, G Leder, A Formentini, et al.
Clinical and Experimental Immunology|June 1, 1997
Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and IL-10 relates to resistance to experimental autoimmune myasthenia gravis (EAMG) in young Lewis ratsF D Shi, G X Zhang, X F Bai, et al.
Journal of the Neurological Sciences|March 1, 1991
Anti-presynaptic membrane receptor antibodies in myasthenia gravisC Z Lu, H Link, X A Mo, et al.
Pageof 68

Showing results (481-490 of 673) with videos related to

Sort By:
Pageof 68
International Immunology|September 29, 2000
Tumor necrosis factor receptor-1 is critically involved in the development of experimental autoimmune myasthenia gravisH B Wang, H Li, F D Shi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 2001
Anti-CTLA-4 antibody treatment triggers determinant spreading and enhances murine myasthenia gravisH B Wang, F D Shi, H Li, et al.
Langenbeck'S Archives of Surgery|June 26, 1998
Resection and radiochemotherapy of pancreatic cancer--the future?K H Link, A Formentini, G Leder, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 26, 2008
Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1A Sanna, Y M Huang, G Arru, et al.
Journal of Neuroimmunology|January 1, 1996
Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosisV Navikas, D Matusevicius, M Söderström, et al.
The New England Journal of Medicine|May 12, 1988
Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coliC O Tacket, G Losonsky, H Link, et al.
Clinical Immunology (Orlando, Fla.)|August 31, 2000
Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis ratsL Y Xu, J S Yang, Y M Huang, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 13, 1999
Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment conceptsK H Link, G Leder, A Formentini, et al.
Clinical and Experimental Immunology|June 1, 1997
Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and IL-10 relates to resistance to experimental autoimmune myasthenia gravis (EAMG) in young Lewis ratsF D Shi, G X Zhang, X F Bai, et al.
Journal of the Neurological Sciences|March 1, 1991
Anti-presynaptic membrane receptor antibodies in myasthenia gravisC Z Lu, H Link, X A Mo, et al.
Pageof 68